Different genetic control of cutaneous and visceral disease after Leishmania major infection in mice

Infection and Immunity

Volumn 71, Issue 4, 2003, Pages 2041-2046

  Vladimirov, Vladimir ^a,d   Badalová, Jana ^a,b   Svobodová, Milena ^b   Havelková, Helena ^a   Hart, Augustinus A M ^c   Blažková, Hana ^a   Demant, Peter ^c,e   Lipoldová, Marie ^a,b  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 2; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE LOCUS; GENETIC REGULATION; GENETIC VARIABILITY; HEPATOMEGALY; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SKIN DISEASE; SPECIES DIFFERENCE; SPLENOMEGALY; VISCERA;

ANIMALS; CHROMOSOME MAPPING; CROSSES, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATOMEGALY; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; LINKAGE (GENETICS); MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; SPLENOMEGALY;

EID: 0037378953     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.4.2041-2046.2003     Document Type: Article

References (29)

1. Badalová, J., M. Svobodová, H. Havelková, V. Vladimirov, J. Vojtíšková, J. Engová, T. Pilčík, P. Volf, P. Demant, and M. Lipoldová. 2002. Separation and mapping of multiple genes that control IgE level in Leishmania major infected mice. Genes Immun. 3:187-195.
2. Baldini, M., I. C. Lohman, M. Halonen, R. P. Erickson, P. G. Holt, and F. D. Martinez. 1999. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 20:976-983.
3. Beebe, A. M., S. Mauze, N. J. Schork, and R. L. Coffman. 1997. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6:551-557.
4. Bogdan, C., M. Röllinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173:17-26.
5. Demant, P., and A. A. M. Hart. 1986. Recombinant congenic strains: a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics 24:416-422.
6. Demant, P., M. Lipoldová, and M. Svobodová. 1996. Resistance to Leishmania major in mice. Science 274:1392-1393.
7. Diamond, L. S., and C. M. Herman. 1954. Incidence of trypanosomes in the Canada goose as revealed by bone marrow culture. J. Parasitol. 40:195-202.
8. Garcia, A., S. Marquet, B. Bucheton, D. Hillaire, M. Cot, N. Fievet, A. J. Dessein, and L. Abel. 1998. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am. J. Trop. Med. Hyg. 58:705-709.
9. Gorham, J. D., M. L. Giiler, R. G. Steen, R. J. Mackey, M. I. Daly, K. Frederick, W. F. Dietrich, and K. M. Murphy. 1996. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc. Natl. Acad. Sci. USA 93:12467-12472.
10. Güler, M. L., J. D. Gorham, C.-S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271:984-987.
11. Krulová, M., H. Havelková, M. Kosarová, V. Holán, A. A. M. Hart, P. Demant, and M. Lipoldová. 1997. IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations. Genomics 42:11-15.
12. Lander, E., and L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting results. Nat. Genet. 11:241-247.
13. Lee, G. H., L. M. Benett, R. A. Carabeo, and N. R. Drinkwater. 1995. Identification of hepatocarcinogen resistance genes in DBA/2 mice. Genetics 193:387-397.
14. Lipoldová, M., M. Svobodová, H. Havelková, M. Krulová, J. Badalová, E. Nohýnková, A. A. M. Hart, D. Schlegel, P. Volf, and P. Demant. 2002. Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis. Immunogenetics 54:174-183.
15. Lipoldová, M., M. Svobodová, M. Krulová, H. Havelková, J. Badalová, E. Nohýnková, V. Holán, A. A. M. Hart, P. Volf, and P. Demant. 2000. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun. 1:200-206.
16. Marquet, S., L. Abel, D. Hillaire, H. Dessein, J. Kalil, J. Feingold, J. Weissenbach, and A. J. Dessein. 1996. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14:181-184.
17. Molyneux, D. H., and R. Killick-Kendrick. 1987. Morphology, ultrastructure and life cycles, p. 121-176. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. I. Academic Press, London, United Kingdom
18. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
19. Roberts, L. J., T. M. Baldwin, J. M. Curtis, E. Handman, and S. J. Foote. 1997. Resistance to Leishmania major is linked to H2 region on chromosome 17 and to chromosome 9. J. Exp. Med. 9:1705-1710.
20. Roberts, L. J., T. M. Baldwin, T. P. Speed, E. Handman, and S. J. Foote. 1999. Chromosomes X, 9 and the H2 locus interact epistatically to control Leishmania major infection. Eur. J. Immunol. 29:3047-3050.
21. Roberts, M., B. A. Mock, and J. M. Blackwell. 1993. Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice. Eur. J. Immunogenet. 20:349-362.
22. Roper, R. J., J. J. Weis, B. A. McCracken, C. B. Green, Y. Ma, K. S. Weber, D. Fairbairn, R. J. Butterfield, M. R. Potter, J. F. Zachary, R. W. Doerge, and C. Teuscher. 2001. Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun. 2:388-397.
23. Sander, C. 2000. Genomic medicine and the future of health care. Science 287:1977-1978.
24. Solbach, W., and T. Laskay. 1996. Evasion strategies of Leishmania parasites, p. 25-47. In F. J. Tapia, G. Cáceres-Dittmar, and M. A. Sánchez (ed.), Molecular and immune mechanisms in the pathogenesis of cutaneous leishmaniasis. R. G. Landes Company, Austin, Tex.
25. Stassen, A. P. M., P. C. Groot, J. T. Eppig, and P. Demant. 1996. Genetic composition of the recombinant congenic strains. Mamm. Genome 7:55-58.
26. Stenger, S., N. Donhauser, H. Thüring, M. Röllinghoff, and C. Bogdan. 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183:1501-1514.
27. Theodos, C. M., A. Shankar, A. L. Glasebrook, W. D. Roeder, and R. G. Titus. 1994. The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis. Parasite Immunol. 16:571-577.
28. van Wezel, T., M. Lipoldová, and P. Demant. 2001. Identification of disease susceptibility genes (modifiers) in mouse models: cancer and infectious diseases, p. 107-130. In S. Malcolm and J. Goodship (ed.), Genotype to phenotype, 2nd ed. BIOS Scientific Publishers Ltd., Oxford, United Kingdom
29. van Wezel, T., A. P. M. Stassen, C. J. A. Moen, A. A. M. Hart, M. A. van der Valk, and P. Demant. 1996. Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat. Genet. 14:468-470.